Precision Medicine
Plasmid DNA and viral vectors as the cornerstones of tailored, targeted treatments
Molecular Cloning & Mutagenesis Projects Completed
Viral Vector Packaging Solutions Delivered
Plasmid DNA Preparations Successfully Produced
In precision medicine, plasmid DNA and viral vectors serve as powerful tools for delivering targeted genetic instructions to cells, enabling precise modification of genes involved in various diseases. These advanced methods are transforming the field by allowing highly specific genetic interventions, paving the way for innovative therapies for complex and rare genetic disorders. This progress offers patients renewed hope for healthier lives and greater potential for recovery.
What exactly is precision medicine and how does plasmid DNA and or viral vectors play a role? We are glad you asked!
The Role of Plasmid DNA and Viral Vectors in Precision Medicine
Plasmid DNA in Precision Medicine
Basics:
- Structure: Plasmid DNA is circular, double-stranded DNA that can be engineered to carry specific genes.
- Usage: Plasmids are commonly used to introduce new genes into cells. These genes can then produce proteins or modify cellular pathways.
- Application: They are widely used for gene expression studies, producing therapeutic proteins, and gene editing (e.g., CRISPR-Cas9 components).
Process:
- Engineering: The plasmid DNA is designed to include therapeutic genes, regulatory elements, or gene-editing components.
- Delivery: Plasmids are introduced to target cells either by transfection (directly introducing DNA) or by packaging, such as adenovirus packaging, lentivirus packaging, or retrovirus packaging, into viral vectors.
- Expression: Once inside the cell, plasmid DNA can begin expressing the desired genes, leading to protein production or gene modifications.
Expected Outcomes:
- Disease Modification: Plasmids can correct genetic mutations, silence harmful genes, or introduce beneficial genes.
- Therapeutic Protein Production: In some cases, plasmid DNA can enable cells to produce therapeutic proteins that alleviate symptoms or address underlying conditions.
Viral Vectors in Precision Medicine
Basics:
- Structure: Viral vectors are viruses modified to carry therapeutic genes but stripped of pathogenic components to make them safe.
- Type: Common viral vectors include lentivirus, adenovirus, adeno-associated virus (AAV), and retrovirus, each with unique delivery capabilities and tissue targeting preferences. AAV vectors are particularly noteworthy for their low immunogenicity and high tissue specificity.
- Application: Viral vectors are essential for gene therapy, where they serve as vehicles to deliver therapeutic genes to specific tissues or cells.
Process:
- Gene Packaging: Therapeutic genes are inserted into the viral genome. In AAV vectors, this process involves carefully selecting appropriate serotypes to ensure optimal cellular targeting and gene delivery.
- Infection and Delivery: The virus infects target cells, delivering the therapeutic gene directly into the cellular DNA.
- Gene Expression: The target cells then express the inserted gene, potentially correcting or modifying disease-related pathways.
Expected Outcomes:
- Genetic Correction: By inserting functional genes, viral vectors can compensate for genetic mutations in inherited diseases.
- Rapid Gene Expression: Adenoviral vectors typically result in transient expression, making them ideal for short-term therapies.
- Long-Term Gene Expression: Some viral vectors, like lentivirus, can integrate into the host genome, providing prolonged gene expression.
- Targeted Therapy: Viral vectors can be engineered to target specific cell types, increasing precision and reducing off-target effects.
Combined Plasmid DNA and Viral Vector Impact in Precision Medicine
Together, plasmid DNA and viral vectors enable highly targeted genetic modifications, providing personalized and potentially curative treatments. Outcomes can vary based on the disease, but the goals are typically:
- Enhanced Safety and Efficacy: By targeting disease-causing genes specifically, precision medicine aims to minimize side effects.
- Personalization: These tools allow treatments to be tailored to individual genetic profiles.
- Durability of Effects: Certain gene therapies may provide long-lasting or permanent relief from symptoms.
Plasmid DNA and Viral Vector Applications in Precision Medicine
Gene Therapy
Gene therapy involves directly modifying genes within a patient’s cells to treat or prevent disease. Both plasmid DNA, adenoviral, and lentiviral/retroviral vectors are used in this approach. Read more about plasmid DNA and viral vectors in cell and gene therapy.
- Plasmid DNA: Used to introduce therapeutic genes for temporary expression or as a DNA template for gene-editing tools (e.g., CRISPR-Cas9). While plasmids don’t integrate into the genome, they’re useful in cases where transient gene expression is sufficient.
- Adenoviral Vectors:c Deployed in gene replacement therapies for cystic fibrosis, delivering functional copies of defective genes directly to lung cells.
- Lentiviral and Retroviral Vectors: These vectors can integrate therapeutic genes into the host genome, enabling stable, long-term expression. This is critical for treating inherited genetic disorders, such as hemophilia, cystic fibrosis, and Duchenne muscular dystrophy, where ongoing expression of a corrected gene is needed to produce a missing or dysfunctional protein.
- Examples:
CAR-T Cell Therapy
CAR-T cell therapy is a type of immunotherapy that involves engineering a patient’s own T cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. Learn more about plasmid DNA and viral vectors in immunotherapy.
- Plasmid DNA: Used in the initial stages to develop constructs that encode chimeric antigen receptors (CARs), which are introduced into T cells to reprogram them for targeting cancer cells.
- AAV, Adenoviral, Lentiviral, and Retroviral Vectors: Introduce CAR genes into T cells. Adenoviral vectors can be used to deliver immunomodulatory genes that enhance CAR-T cell function. AAV can be used to introduce CAR genes into T cells, with specific serotypes enhancing cellular targeting and gene delivery efficiency. Lentiviral vectors are particularly useful in CAR-T therapies because of their expanded cargo capacity.
- Examples:
Gene Editing
Gene editing enables precise modifications to DNA sequences to correct genetic mutations, deactivate harmful genes, or introduce beneficial genes.
- Plasmid DNA: Commonly used to carry the CRISPR-Cas9 machinery (Cas9 enzyme and guide RNA) as a template. The plasmid facilitates initial gene-editing experiments and can be used for in vitro studies or transient delivery.
- AAV, Lentiviral, and Retroviral Vectors: Employed to deliver the gene-editing components into specific cell types. This is beneficial for conditions like sickle cell disease and beta-thalassemia, where a single gene edit can potentially provide a permanent cure by correcting blood stem cells. AAV vectors are increasingly used to deliver CRISPR-Cas9 components, offering precise gene modification capabilities. Read more about plasmid DNA and viral vectors in stem cell treatments and therapeutics.
- Examples:
- Exa-Cel – Vertex Pharmaceuticals/CRISPR Therapeutics
Cancer Gene Therapy and Oncolytic Virus Therapy
For solid tumors and cancers beyond blood malignancies, gene therapy is used to enhance the body’s natural immune response or directly alter cancer cells’ genetic makeup. Learn more about plasmid DNA and viral vectors in oncology.
- Plasmid DNA: Can be used to deliver tumor-suppressing genes or immunomodulatory factors that stimulate the immune system to target cancer cells.
- AAV, Lentiviral, and Retroviral Vectors: These vectors deliver genes that make cancer cells more recognizable to the immune system or enhance sensitivity to chemotherapy. For example, a viral vector may introduce a gene that makes cancer cells express specific antigens, allowing T cells to recognize and destroy them more effectively. AAV vectors show promising potential in oncology for delivering tumor-suppressing genes, introducing immunomodulatory factors, and enhancing immune system recognition of cancer cells.
- Examples:
- INO-4800 – Inovio Pharmaceuticals
- T-VEC Imlygic – Amgen
Regenerative Medicine and Stem Cell Engineering
Lentiviral and retroviral vectors are used to modify stem cells in regenerative medicine, which can treat a range of degenerative diseases and injuries.
- Plasmid DNA: Often serves as a template for delivering factors that induce stem cell differentiation. It’s especially useful for in vitro research or producing specific proteins needed for regenerative therapies.
- Lentiviral and Retroviral Vectors: Used for more stable integration of genes that promote the differentiation of stem cells into specific cell types, such as neurons, cardiac cells, or pancreatic cells. This is promising for conditions like Parkinson’s disease, type 1 diabetes, and cardiac diseases, where new cell growth is needed to replace damaged tissue.
Vaccines and Immunotherapies
Gene-based vaccines and immunotherapies that involve genetic material to provoke an immune response against specific antigens are a rapidly growing area. Read more about plasmid DNA and viral vectors in vaccine development.
- Plasmid DNA: Common in DNA vaccines, which encode viral or bacterial antigens that, once expressed, trigger an immune response. DNA vaccines have been explored for COVID-19, HIV, Zika, and other infectious diseases.
- Lentiviral and Retroviral Vectors: These vectors can introduce genes that stimulate a stronger or more specific immune response, and they have been used in cancer immunotherapies to help the immune system target tumor-associated antigens.
- AAV Vectors: These vectors are emerging as powerful tools for developing targeted vaccine approaches, cancer immunotherapies, and genetic vaccines with improved specificity.
Neurological and Neurodegenerative Disease Therapies
Neurological diseases like Huntington’s disease, ALS, and spinal muscular atrophy involve genetic mutations that may be addressed using plasmid and viral vector technologies.
- Plasmid DNA: Delivers short-term gene-editing or gene-silencing tools (e.g., siRNA or shRNA) to reduce harmful gene expression in the nervous system.
- AAV and Adenoviral Vectors:: Enable short-term delivery of genes that encode neuroprotective factors or correct genetic mutations in diseases like ALS or Huntington’s disease. AAV in particular has shown progress in treating conditions including Parkinson’s, Huntington’s disease, and spinal muscular atrophy.
- Lentiviral and Retroviral Vectors: Due to their ability to integrate into cells, lentiviral vectors are explored for longer-term delivery of genes that provide neuroprotective effects or replace mutated genes.
- Examples:
Molecular Cloning, Mutagenesis, AAV Packaging, Adenovirus Packaging, Lentivirus Packaging, Retrovirus Packaging, and CRISPR-Cas9 Services for Precision Medicine R&D
cOur laboratory specializes in plasmid DNA and viral vector services for regenerative medicine discovery phase research including:
If you have a question about your plasmid DNA and viral vector based precision medicine research, contact our team.
Trusted By Top Researchers Across Disciplines and Therapeutic Areas
Subscribe for Product Releases, New Resources, and Company Updates
13 Taft Court Suite 220
Rockville, MD 20850
(301) 838-8675
Follow Us on LinkedIn
© 2025 BioInnovatise, All Rights Reserved